Lv1
28 积分 2025-01-25 加入
THE METABOLIC DISPOSITION OF APREPITANT, A SUBSTANCE P RECEPTOR ANTAGONIST, IN RATS AND DOGS
7天前
已完结
Effects of Cytochrome P450 enzymes and drug–drug interaction on donafenib metabolism: in vivo, in vitro and in silico
9天前
已完结
Development, validation and application of a UPLC-MS/MS method for simultaneous quantification of OPC-61815 and its metabolites tolvaptan, DM-4103 and DM-4107 in human plasma
10天前
已完结
Simple Liquid Chromatography–Tandem Mass Spectrometry Method for Quantitation of Total and Free Aprepitant and Its Active N-Dealkylated Metabolites in Human Plasma
18天前
已完结
Development of an UPLC-MS/MS method for quantification of donafenib and its metabolite in rat plasma: application to drug–drug interaction
1个月前
已完结
Qualitative and Quantitative Assessment of Drug-Drug Interaction Potential in Man, Based on Ki, IC50 and Inhibitor Concentration
1个月前
已完结
Mixed and non-competitive enzyme inhibition: underlying mechanisms and mechanistic irrelevance of the formal two-site model
1个月前
已完结
Curcumin: An epigenetic regulator and its application in cancer
2个月前
已完结
Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis
2个月前
已完结
Inhibitory effects of the main metabolites of Apatinib on CYP450 isozymes in human and rat liver microsomes
2个月前
已完结